GLP-1 receptor agonist use led to a reduction in components of the composite MACE endpoint separately including risk of death from cardiovascular causes, fatal or non-fatal myocardial infarction, and fatal or non-fatal stroke
This work was funded by the National Key R&D Program of China (2022YFA1302902 to W.S
MT-2 10mg research peptide UK (Melanotan II) is a non-selective melanocortin agonist activating MC1R, MC3R, MC4R and MC5R simultaneously for broad melanocortin system receptor research in UK laboratories
These observations suggest that obesity in KOA is not merely a background characteristic but a biologically and clinically relevant disease driver
Growth hormone influences protein synthesis, fat mobilization, and bone density, while tirzepatide's primary action revolves around glucose regulation and satiety
GLP-1 agonists like semaglutide and tirzepatide slow gastric emptying by 30-40% as part of their mechanism of action (Nauck et al., Diabetologia, 2011)